1. Home
  2. WFCF vs LUNG Comparison

WFCF vs LUNG Comparison

Compare WFCF & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Where Food Comes From Inc.

WFCF

Where Food Comes From Inc.

N/A

Current Price

$12.16

Market Cap

61.3M

Sector

Technology

ML Signal

N/A

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.35

Market Cap

72.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFCF
LUNG
Founded
1996
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.3M
72.2M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
WFCF
LUNG
Price
$12.16
$1.35
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$5.38
AVG Volume (30 Days)
1.2K
680.2K
Earning Date
05-07-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.64
EPS
0.30
N/A
Revenue
$20,774,416.00
$90,497,000.00
Revenue This Year
N/A
$6.20
Revenue Next Year
N/A
$21.61
P/E Ratio
$39.19
N/A
Revenue Growth
16.69
8.01
52 Week Low
$9.69
$1.31
52 Week High
$13.70
$7.97

Technical Indicators

Market Signals
Indicator
WFCF
LUNG
Relative Strength Index (RSI) 58.25 37.62
Support Level $11.90 N/A
Resistance Level $12.68 $2.01
Average True Range (ATR) 0.16 0.17
MACD -0.03 -0.03
Stochastic Oscillator 87.21 5.29

Price Performance

Historical Comparison
WFCF
LUNG

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company conducting both on-site and desk audits to verify that claims being made about livestock, food, other high-value specialty crops and agricultural and aquaculture products are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. It also provides a wide range of professional consulting services. It generates the majority of its revenue from Verification and certification services.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: